Diarrhea News and Research

Latest Diarrhea News and Research

New molecular research shows how antidepressants work

New molecular research shows how chemically diverse drugs used to treat depression and anxiety disorders interact with the protein that transports serotonin in the brain.

29 Jan 2018

Patients with IBS could benefit from vitamin D supplements, suggests new research

According to a new study, taking vitamin D supplements can help to relieve the painful symptoms of Irritable Bowel Syndrome (IBS).

29 Jan 2018

UEA researchers unravel secret behind success of giardia parasites

Giardia parasites - responsible for one of the world's most common gastric diseases - are able to mimic human cell functions to break apart cells in the gut and feed off them, new research has shown.

29 Jan 2018

Expert discusses how to stay healthy during flu season

This year's influenza outbreak is already the most widespread on record since health officials began keeping track about a dozen years ago, with millions of Americans being infected by emerging and current strains such as the dominant H3N2.

18 Jan 2018

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

15 Jan 2018

Energy drinks can have adverse health effects on youth, study reveals

Over half of Canadian youth and young adults who have consumed energy drinks have experienced negative health effects as a result, according to a study from the University of Waterloo.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

SHEA releases new guidance on contact precautions for drug-resistant infections

New expert guidance released today by the Society for Healthcare Epidemiology of America advises hospitals on determining when they can safely discontinue contact precautions for patients with multi-drug resistant bacteria.

11 Jan 2018

Warning on the “raw water” drinking trend

For a few years now several companies have been marketing “raw water” that has been bottled directly from natural sources such as springs and small water bodies without filtration and treatment.

11 Jan 2018

Malnutrition remains underdiagnosed, undertreated for decades among hospitalized patients

Malnutrition among hospitalized patients remains a serious issue that has been underdiagnosed and undertreated for decades.

9 Jan 2018

Study finds link between dietary sugar and increasing bacterial epidemics

The rising frequency and severity of Clostridium difficile infections may be caused by the commonly used food additive, trehalose, according to Nature.

5 Jan 2018

Mobidiag introduces new fully automated diagnostic solution for infectious diseases

Mobidiag, a Finnish molecular diagnostics company, launches Novodiag, a fully automated solution for syndromic and targeted testing of infectious diseases, supporting limitation of antibiotic use.

4 Jan 2018

Dietary sugar may contribute to increasing frequency, severity of bacterial epidemics

The increasing frequency and severity of healthcare-associated outbreaks caused by bacterium Clostridium difficile have been linked to the widely used food additive trehalose.

3 Jan 2018

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.

26 Dec 2017

Survey shows prevalence of diarrhea in people living with HIV

Napo Pharmaceuticals, Inc., a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc., today released the results of a survey of 350 people living with HIV and AIDS on "Talking to Your Doctor About Symptoms".

13 Dec 2017

Single-dose oral vaccine could be effective tool in controlling cholera outbreaks

Each year there are more than three million cases of cholera worldwide, a disease transmitted through contaminated food and water that hits developing countries particularly hard.

12 Dec 2017

Opioids after surgery left her addicted. Is that a medical error?

In April this year, Katie Herzog checked into a Boston teaching hospital for what turned out to be a nine-hour-long back surgery.

11 Dec 2017

Kent researchers establish first long-term cultivation system for diarrhea-causing parasite

A research team at the University of Kent has established the first long-term cultivation system at a laboratory scale for the parasite Cryptosporidium, one of the world's worst and most common causes of diarrhea and death from diarrhea.

4 Dec 2017

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

4 Dec 2017

Capsule research could transform treatment for C. difficile infections

An Alberta-led clinical trial has shown Fecal Microbiota Transplant (FMT) is as effective in treating clostridium difficile (C. difficile) infections whether delivered by colonoscopy or by swallowing capsules.

28 Nov 2017

Diarrhea News and Research

Latest Diarrhea News and Research

New molecular research shows how antidepressants work

Patients with IBS could benefit from vitamin D supplements, suggests new research

UEA researchers unravel secret behind success of giardia parasites

Expert discusses how to stay healthy during flu season

FDA grants approval for first drug to treat inherited breast cancer

Energy drinks can have adverse health effects on youth, study reveals

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

SHEA releases new guidance on contact precautions for drug-resistant infections

Warning on the “raw water” drinking trend

Malnutrition remains underdiagnosed, undertreated for decades among hospitalized patients

Study finds link between dietary sugar and increasing bacterial epidemics

Mobidiag introduces new fully automated diagnostic solution for infectious diseases

Dietary sugar may contribute to increasing frequency, severity of bacterial epidemics

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Survey shows prevalence of diarrhea in people living with HIV

Single-dose oral vaccine could be effective tool in controlling cholera outbreaks

Opioids after surgery left her addicted. Is that a medical error?

Kent researchers establish first long-term cultivation system for diarrhea-causing parasite

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

Capsule research could transform treatment for C. difficile infections

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Diarrhea News and Research

Latest Diarrhea News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in